Rapid early progression (REP) of glioblastoma is an independent negative prognostic factor: Results from a systematic review and meta-analysis.
Mueez WaqarFederico RoncaroliEric J LehrerJoshua D PalmerJavier Villanueva-MeyerSteve BraunsteinEmma HallMarianne AznarPhilip C De Witt HamerPietro I D'UrsoDaniel M TrifilettiAlfredo Quiñones-HinojosaPieter WesselingGerben R BorstPublished in: Neuro-oncology advances (2022)
REP occurs in almost half of patients with newly diagnosed glioblastoma and has a strongly negative prognostic effect. Future studies should investigate its biology and effective treatment strategies.
Keyphrases